Clinical Trial Update: An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 open study evaluating the bioavailability of a modified formulation of tacrolimus in kidney transplant recipient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Prograf (Tacrolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED